epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove Onyda XR
    clonidine
  • remove Xelstrym
    dextroamphetamine transdermal

multicheck MultiCheck Results - 1 Interaction

Smiley face Smiley face

Monitor/Modify Tx

Smiley face Smiley face Onyda XR (clonidine) + Xelstrym (dextroamphetamine transdermal)

Monitor/Modify Tx


clonidine + dextroamphetamine

monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

Additional Considerations

Smiley face Smiley face clonidine in Onyda XR

avoid combo with beverages or products containing ethanol and clonidine extended-release (ER) suspension or tablets; combo may incr. clonidine release rate, levels, risk of adverse effects, decr. duration of efficacy

Smiley face Smiley face dextroamphetamine in Xelstrym

add MAO inhibitor to Interaction Check if recent (14 days) use

avoid combo with beverages or products containing ethanol and Mydayis; combo may incr. dextroamphetamine release rate, levels, risk of adverse effects, decr. duration of efficacy

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information